Please upgrade your browser.
From the Journal of Clinical Oncology
Crow rocks St. Louis for cancer awareness Rocker, Costello kick off All-Star festivities for charity
Crow was at the MLB All-Star Concert to help support Stand Up To Cancer.
Video courtesy of pennlive.com
About 4:15 into this YouTube interview, actress Denise Richards mentions the Kidney Cancer Association (KCA). The KCA will be featured in an episode of the E! reality TV series, "It's Complicated."
The company's lead product, tivozanib (AV-951), a triple VEGF receptor inhibitor, recently completed Phase 2 clinical development in patients with metastatic renal cell cancer and is expected to enter Phase 3 development in 2009.
In the event, the Nittany Lions, in teams of four, are put through a series of grueling strength and conditioning exercises. By the end of the gauntlet, they are spent. But they are also feeling better about themselves, as money raised at the event supports the Kidney Cancer Association.
Ongoing clinical development includes six interpatient dose escalation studies, with starting doses varying from 3 µg/kg/week to 60 µg/kg/week, to evaluate the safety and biological activity of CYT107 in various indications. These studies include: CLI-107-04: a monocentric Phase I interpatient non-controlled dose escalation study in oncology (metastatic melanoma or renal cell carcinoma), conducted at the US National Cancer Institute, Bethesda, Maryland.
American scientists suggest that drinking daily three or more cups of tea or coffee can protect individuals against kidney cancers. Although many believe milk, soda and juice are the healthy drinks, the study published in the International Journal of Cancer shows they have no impact on cutting kidney cancer risk.
OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance
"In the last eight months, OncologyRx Care Advantage has helped more than 1,300 patients receive more than $5 million in financial assistance from charitable foundations. The US Oncology pharmacy announced it had reached the $10 million mark in November 2008." Courtesy of pharmacychoice.com
|Powered by NeonCRM|